International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Paula Schaiquevich Q&A

Schaiquevich 150x200 Our second blog interview is with Paula Schaiquevich, CONICET researcher at the Paediatric Hospital Dr. Juan P Garrahan in Buenos Aires, Argentina. Paula's research work involves pharmacokinetic/ pharmacodynamic studies of chemotherapy and development of new routes/new drugs for patients with retinoblastoma.

Daan Touw Q&A

At the IATDMCT Stuttgart congress in 2011 Pierre Marquet presented the results of an inquiry amongst members to describe their innovations/initiatives in TDM and Clinical Toxicology. The idea behind this blog is to showcase some of the initiatives presented there and to continue cataloguing the great things our members do.

The first interview was with Dan Touw, head of the clinical pharmaceutical and toxicological laboratory at the University Medical Center in Groningen. Dan uses dose adaptation software in clinical practice, and together with other colleagues, hosts an annual national training program for such software.

Compass Interview with Pierre Wallemacq

Wallemacq 150x200First of all we would like to congratulate you on your IATDMCT presidency and wish you a very successful and enjoyable 2013–2015 term.

We are particularly pleased and grateful about your agreement to give us the first interview for our new column “IATDMCT Mentors Interview”. With this column of the Compass we would like to give longstanding IATDMCT members the opportunity to share their experience both in the field of TDM/CT and as active members of IATDMCT with our young colleagues.

We are confident that the answers to the questions we have put together will offer invaluable tips for their individual professional development and encourage them to actively participate in shaping the future of IATDMCT.

Page 9 of 9

The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.